Main Article Content

Abstract

The leaves of khat plant (Catha edulis) are widely consumed by people of East African countries and Arabian Peninsula for their pleasurable and stimulating effects. The consumption of khat is prohibited in the Kingdom of Saudi Arabia but it is being used by the people of Kingdom, especially in the region of Jazan, where it is easily available due to its cultivation in the neighbouring country Yemen. The objective of the study was to evaluate the effect of very low doses of cathinone on the brain lipids. Male Swiss albino mice were divided in 4 groups, one control and 3 experimental and each group having 6 animals. (-) Cathinone, 0.125, 0.25 and 0.5 mg/kg body weight was given intraperitoneal to animals for 10 days, once daily.  Cathinone has elevated the level of triglyceride significantly and dose dependently as compared to control group. On the other hand, the content of ganglioside was depleted significantly and dose dependently in experimental groups as compared to control group. A significantly elevated level of cholesterol was observed with the doses of 0.25 and 0.5 mg/kg and phospholipids with the dose of 0.5 mg/kg of cathinone as compared to control group. No significant change on total lipids was observed in cathinone treated group as compared to control group. The study concludes that very low doses of cathinone were sufficient for the change on the brain lipid contents to provide excitement in khat chewers. 

Keywords

Brain lipids (phospholipids, triglyceride, cholesterol, gangliosides) Catha edulis Cathinone Swiss albino mice

Article Details

How to Cite
Safhi, M. M. ., Alam, M. F. ., Jubran Khardali, I. A., Hussain, S. ., Hakeem Siddiqui, M. A. ., Khuwaja, G. ., Al-Sanosi, R. M. ., & Islam, F. . (2014). Toxic effect of cathinone (an active principle of Catha edulis) on brain lipids in Swiss albino mice. Environment Conservation Journal, 15(1&2), 5–11. https://doi.org/10.36953/ECJ.2014.151202

References

  1. Al-Habori M and Al-Mamary M., 2004. Long-term feeding effects of Catha edulis leaves on blood constituents in animals. Phytomedicine, 11: 639- 644.
  2. Al-Hebshi NN and Skaug N., 2005. Khat (Catha edulis)—an updated review. Addict Biol 10:299-307.
  3. Al-Rajhi W.I. and Yousef O.M., 2013. Effects of Catha edulis abuse on glucose, lipids profiles and liver histopathology in rabbit. Journal of Life Sciences and Technologies, 1(1):33-37.
  4. Al-Zubairi A, Al-Habori M, and Al-Geiry A., 2003. Effect of Catha edulis (khat) chewing on plasma lipid peroxdation. J. Ethnopharmacol. 87: 3-9.
  5. Balint E.E, Falkay G. and Balint G.A., 2009. Khat-A Controversial Plant. Wien KlinWochenschr 121:604-614.
  6. Block R. C., Dorsey E.R., Beck C.A., Brenna J. and Shoulson I., 2010. Altered cholesterol and fatty acid metabolism in Huntington disease. Journal of Clinical Lipidology, 4 (1): 17–23.
  7. Brante G., 1949. Studies on lipids in the nervous system: with special reference to quantitative chemical determination and topical distribution, Acta Physiol. Scand., 18: 63–67.
  8. Chaves E.I.P., Rusinol A.E., Vance D.E., Campenot R.B. and Vance J.E., 1997. Role of lipoproteins in the delivery of lipids to axons during axonal regeneration. The Journal of Biological Chemistry, 272:30766–30773.
  9. De Barber A.E., Eroglu Y., Merkens L.S.,Pappu A.S., Steiner R.D., 2011. Smith-Lemli- Opitz syndrome. Expert Reviews in Molecular Medicine, 13: 24.
  10. Di Paolo G. and T. W. Kim T.W., 2011. Linking lipids to Alzheimer’s disease: Cholesterol and beyond. Nature Reviews Neuroscience, 12(5): 284–296.
  11. Dimba E.A., Gjertsen B.T., Bredholt T., Fossan K.O., Costea D.E., Francis G.W., Johannessen A.C., Vintermyr O.K., 2004. Khat (Catha edulis)-induced apoptosis is inhibited by antagonists of caspase-1 and-8 in human leukaemia cells. Br J Cancer 91:1726–34.
  12. Elmi A.S.., 1983. The chewing of khat in Somalia. J Ethnopharmacol, 8:163-76.
  13. Fester L., Zhou L., Butow A.,Huber C., V, Prange-Kiel J., Jarry H., Rune G.M..2009. Cholesterol-promoted synaptogenesis requires the conversion of cholesterol to estradiol in the hippocampus. Hippocampus, 19: 8, 692–705.
  14. Fiske C.H. and Subbarow Y., 1925. The colorimetric determination of phosphorus, J. Biol. Chem.66: 375–400.
  15. Folch, J., Ascoli I., Lees, M. Meath, J.A. and LeBaron F.N., 1951. Preparation of lipid extracts from brain tissue, J. Biol. Chem.191, 833–841.
  16. Geisshüsler, S. and Brenneisen, R., 1987. The content of psychoactive phenylpropyl and phenylpentenylkhatamines in Catha edulis Forsk of different origin. J Ethnopharmacol, 19:269–77.
  17. Goritz, C., Mauch D.H. and Pfrieger, F.W., 2005. Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron. Molecular and Cellular Neuroscience, 29:2, 190–201.
  18. Halliwell, B., 1989. Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson’s disease, Alzheimer’s disease, traumatic injury or stroke? Acta Neurol. Scand., 126: 23–33.
  19. Hassan, N.A., Gunaid, A.A., El-Khally, F.M., Al-Noami M.Y. and Murray-Lyon I.M., 2005. Khat chewing and arterial blood pressure. A randomized controlled clinical trial of alpha-1 and selective beta-1 adrenoceptor blockade. Saudi Med. J. 26(4):537-541.
  20. Henly A.A., 1957. The determination of serum cholesterol, Analyst82: 286–287.
  21. Herz, J. and Bock, H.H., 2002. Lipoprotein receptors in the nervous system. Annual Review of Biochemistry, 71: 405–434.
  22. Irwin, L.N. and Samson, F.E., 1971. Content and turnover of gangliosides in rat brain following behavioural stimulation. J. Neurochem. 18: 203-211.
  23. Islam, F.,Hasan, M. and Saxena, K. 1986. Isolation and estimation of gangliosides in discrete areas of the forebrain: Effects of estrogen on regional lipid profiles. Expt. Pathol. 29: 159-164.
  24. Islam, F., Hasan, M., Rizvi, R., and Osman, S.M., 1980. Microanalysis of lipids in discrete brain areas of the rabbit following intramuscular administration of steroid contraceptive, Contraception, 21, 433–442.
  25. Kalix, P., 1984. In pharmacology of khat. General Pharmacology, 15: 179-187.
  26. Kalix, P., 1990. Pharmacological properties of the stimulant khat. PharmacolTher, 48:397-416.
  27. Kalix,P., 1992. Cathinone, a natural amphetamine. Pharmacol Toxicol, 70:77– 86.
  28. Kaur, P., Yousuf, S., Ansari, M.A., Ahmad, A.S. and Islam, F. 2003. Dose- and duration-dependent alterations by tellurium on lipid levels. Differential effects in cerebrum, cerebellum and brain stem of mice. Biological Trace Element Res , 94: 259-271.
  29. Koudinov, A.R. and Koudinova,N.V., 2005. Cholesterol homeostasis failure as a unifying cause of synaptic degeneration, Journal of the Neurological Sciences, 229-230: 233– 240.
  30. Mahmood, S.A. and Lindequist ,U., 2008. A pilot study on the effect of Catha edulis Frosk., (Celastraceae) on metabolic syndrome in Wokw rats.Afr J Tradit Complement Altern Med.10: 271-277.
  31. Marinetti, G.V., 1962. Chromatographic separation, identification and analysis of phosphatides, J. Lipid Res.3: 1–20.
  32. Matloob, M.H., 2003. Determination of cadmium, lead, copper and zinc in Yemeni khat by anodic stripping voltammetry.East Mediterr Health J, 9:28-36.
  33. Nencini, P, and Ahmed, A.M. Khat consumption: a pharmacological review, 1989. Drug Alcohol Depend, 23:19–29.
  34. Nencini, P., Ahmed, A.M., Aminconi, G., Elmi, A.S., 1984. Tolerance develops to sympathetic effects of khat in human. Pharmacology, 28:150-154.
  35. Ordy, J.M. and Kaack. B., 1975. In Neurobiology of Aging, JM Ordy and KR Brizzee, eds, Plenum, London, p.264
  36. Pollet S, Ermidou S, LeSaux F, Monge M, and Baumann N, 1978. Microanalysis of brain lipids, multiple two dimensional thin layer chromatographies, J. Lipid Res. 19: 916–921.
  37. Qureshi, S.,Tariq, M.,Elal-Meshal, I. A., 1988. Genetic effects of chronic treatment with cathinone in mice. Mutagenesis.3(6):481-3.
  38. Rahmann, H., 1983. Functional implication of gangliosides in synaptic transmission. A critique. Neurochem. Inter. 5: 539-547.
  39. Schechler, M.D., Rosecrans, J.A. and Glennon, R.A., 1984. Comparison of behavioural effects of cathinone, amphetamine and apomorphine. Pharm. Biochem. Behavior. 20: 181-184.
  40. Warren, L. 1963. The distribution of sialic acids in nature. Comp. Biochem. Physiol. 10: 153-171.
  41. Widler, P., Mathys, K., Brenneisen, R., Kalix, P., Fisch, H.U., 1994. Pharmacodynamics and pharmacokinetics of khat: a controlled study. ClinPharmacolTher, 55:556-62.
  42. Woodman, D.D. and Price, C.P., 1972. Estimation of serum total lipids. Clin. Chim. Acta, 38: 39–43.
  43. Zia, S. and Islam, F., 2000. Selenium altered the levels of lipids, lipid peroxidation and sulfhydryl groups in striatum and thalamus of rat. Biol. Trace Element Res.77: 251–259.